Neonatal cost savings in hypertensive disorders of pregnancy: Economic evaluation of the sFlt-1/PlGF test with real world implementation of biomarkers.

Neonatal cost savings in hypertensive disorders of pregnancy: Economic evaluation of the sFlt-1/PlGF test with real world implementation of biomarkers. Pregnancy Hypertens. 2025 Mar; 39:101190.

View in: PubMed

subject areas

Adult
Biomarkers
Cost Savings
Cost-Benefit Analysis
Decision Trees
Female
Humans
Infant, Newborn
Placenta Growth Factor
Pre-Eclampsia
Pregnancy
Risk Assessment
United States
Vascular Endothelial Growth Factor Receptor-1

authors with profiles

Sarosh Rana